Right ventricular function in valvular heart disease: relation to pulmonary artery pressure

Area of Science:

• Cardiology
• Cardiovascular Physiology

Background:

• Acquired valvular heart disease can impact right ventricular function.
• Pulmonary artery pressure is a critical determinant of right ventricular performance.

Purpose of the Study:

• To investigate the relationship between right ventricular ejection fraction (RVEF) and pulmonary artery pressure in patients with valvular heart disease.
• To assess the effect of pulmonary artery pressure reduction on RVEF.

Main Methods:

• Right ventricular angiography was performed in 46 patients with acquired valvular heart disease and 8 controls.
• Correlation analysis was used to assess the relationship between RVEF, right ventricular peak systolic pressure (RVPSP), and mean pulmonary artery pressure.
• The effect of intravenous nitroglycerin on RVEF and pulmonary artery pressure was evaluated in a subset of patients.

Main Results:

• RVEF strongly correlated with RVPSP and mean pulmonary artery pressure (r = -0.76, p < 0.001).
• 85% of patients with elevated pulmonary artery pressure had abnormally low RVEF.
• Nitroglycerin administration significantly decreased pulmonary artery pressure and improved RVEF (from 43% to 48%, p < 0.05).

Conclusions:

• Elevated pulmonary artery pressure is a major factor contributing to reduced RVEF in valvular heart disease.
• A portion of the RVEF depression is reversible with pharmacologic reduction of pulmonary artery pressure.
• These findings highlight the importance of managing pulmonary artery pressure to preserve right ventricular function.